Normal Human Immunoglobulin Acquisition 5G/100 Ml Iny 100 Ml for the Pharmacy Service of the Santa Rosa Ii-2 Hospital?

PeruTenders notice for Normal Human Immunoglobulin Acquisition 5G/100 Ml Iny 100 Ml for the Pharmacy Service of the Santa Rosa Ii-2 Hospital?. The reference ID of the tender is 123411320 and it is closing on 11 Aug 2025.

100% Secure Payments

Tender Details

  • Country: Peru
  • Summary: Normal Human Immunoglobulin Acquisition 5G/100 Ml Iny 100 Ml for the Pharmacy Service of the Santa Rosa Ii-2 Hospital?
  • PET Ref No: 123411320
  • Deadline: 11 Aug 2025
  • Competition: ICB
  • Financier: Self Financed
  • Purchaser Ownership: Public
  • Tender Value: Refer Document
  • Notice Type: Tender
  • Document Ref. No.: LP-ABR-1-2025-HAPCSR II-2-1
  • Purchaser's Detail :
  • Purchaser : REGIONAL GOVERNMENT OF PIURA-HOSPITAL OF SUPPORT I SANTA ROSA PIURA
    Av. Grade Chulucanas No. S/N to H San Martin Piura
    Website :
    Telephone : 073 -
    Peru
    URL :www.hsantarosa.gob.pe

  • Description :
  • Normal human immunoglobulin acquisition 5g/100 ml iny 100 mL for the pharmacy service of the Santa Rosa II-2 hospital?
  • Documents :
  •  Tender Notice

If you are registered member, kindly login to view full details of this tender notice:

CLICK HERE TO LOGIN
PeruTenders Features

PeruTenders Features

Fresh and verified Tenders from Peru. Find, search and filter Tenders/Call for bids/RFIs/RFPs/RFQs/Auctions published by the government, public sector undertakings (PSUs) and private entities.

  • 1,000+ Tenders
  • Verified Tenders Only
  • Accurate Tender Information
  • New Tenders Every Day
  • Consultants for RFI/RFP/RFQ
  • Search, sort, and filter Tenders
  • Customer Support
  • Publish your Tenders
  • Consulting Services
  • Export data to Excel or CRM

Get A Call From Tender Experts

Fill out the form below and you will receive a call from us within 24 hours.

Thank You for Contacting ZimbabweTenders !!
Email Id is already exist !!
Invalid Captcha !

Get FREE SAMPLE TENDERS from Peru in your email inbox.

  Chat with us